SCHEMBL2462295

SCHEMBL2462295

Cc1cccc(C(=O)N(C)c2ccccc2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 4/20 0.59
HSD17B1 P14061 3/20 0.59
KDM1A O60341 1/20 0.57
MAOA P21397 1/20 0.57
MAOB P27338 1/20 0.57
HPGD P15428 2/20 0.56
KDM4E B2RXH2 1/20 0.56
KMT2A Q03164 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
PLAU P00749 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
ATM Q13315 1/20 0.53
HTT P42858 2/20 0.51
PARP1 P09874 1/20 0.50
POLB P06746 1/20 0.50
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
TSHR P16473 1/20 0.49
NPC1 O15118 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29940968 0.90 HSD17B2 (0.72) HSD17B2HSD17B1KDM1AMAOAMAOB
SCHEMBL10212283 0.90 HSD17B2 (0.72) HSD17B2HSD17B1KDM1AMAOAMAOB
SCHEMBL18774006 0.90 HSD17B2 (0.60) HSD17B2HSD17B1KDM1AMAOAMAOB
SCHEMBL9001650 0.89 MAOA (0.63) HSD17B2KDM1AMAOAMAOBHPGD
SCHEMBL23367854 0.85 GPBAR1 (0.55) HSD17B2HSD17B1HPGDKDM4EKMT2A
SCHEMBL18773818 0.85 SMN1; SMN2 (0.55) HSD17B2HSD17B1KDM1AMAOAMAOB
SCHEMBL5549839 0.84 HPGD (0.57) HSD17B2HSD17B1HPGDKMT2ATDP1
SCHEMBL32688152 0.84 KDM1A (0.58) HSD17B2KDM1AMAOAMAOBHPGD
Water SCHEMBL11233105 0.84 HSD17B2 (0.50) HSD17B2HSD17B1KDM1AMAOAMAOB
Water SCHEMBL11235271 0.84 HSD17B2 (0.50) HSD17B2HSD17B1KDM1AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117024295-B Photo-induced amide dealkylation method and application thereof 广州中医药大学(广州中医药研究院) 2025-06-13 CN disclosed
CN-117024295-A Photo-induced amide dealkylation method and application thereof 广州中医药大学(广州中医药研究院) 2023-11-10 CN disclosed
EP-1773786-B1 FIVE-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-04-26 EP disclosed
US-8410303-B2 Direct conversion of phenols into amides and esters of benzoic acid The Florida State University Research Foundation, Inc. (US) 2013-04-02 US disclosed
US-8410303-B2 Direct conversion of phenols into amides and esters of benzoic acid The Florida State University Research Foundation, Inc. (US) 2013-04-02 US disclosed
US-8410303-B2 Direct conversion of phenols into amides and esters of benzoic acid The Florida State University Research Foundation, Inc. (US) 2013-04-02 US disclosed
US-20120289502-A1 IMIDAZOLE DERIVATIVES KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-11-15 US disclosed
US-8273738-B2 Imidazole derivatives KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-09-25 US disclosed
US-8273738-B2 Imidazole derivatives KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-09-25 US disclosed
US-20110237798-A1 DIRECT CONVERSION OF PHENOLS INTO AMIDES AND ESTERS OF BENZOIC ACID The Florida State University Research Foundation, Inc. (US) 2011-09-29 US disclosed
US-20110237798-A1 DIRECT CONVERSION OF PHENOLS INTO AMIDES AND ESTERS OF BENZOIC ACID The Florida State University Research Foundation, Inc. (US) 2011-09-29 US disclosed
US-20110237798-A1 DIRECT CONVERSION OF PHENOLS INTO AMIDES AND ESTERS OF BENZOIC ACID The Florida State University Research Foundation, Inc. (US) 2011-09-29 US disclosed
US-20100152178-A1 IMIDAZOLE DERIVATIVES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-17 US disclosed
US-20100152178-A1 IMIDAZOLE DERIVATIVES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-17 US disclosed
EP-2090570-A1 IMIDAZOLE DERIVATIVE Kyowa Hakko Kirin Co., Ltd. (JP) 2009-08-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237798-A1 DIRECT CONVERSION OF PHENOLS INTO AMIDES AND ESTERS OF BENZOIC ACID DDC, NISCH, TST HSD17B2 2112/4885HSD17B1 1685/4885KDM1A 842/4885
US-20120289502-A1 IMIDAZOLE DERIVATIVES CNR1, CNR2, ARRB1 HSD17B2 1381/4885HSD17B1 1726/4885KDM1A 1903/4885
US-20100152178-A1 IMIDAZOLE DERIVATIVES CNR1, CNR2, ARRB1 HSD17B2 1381/4885HSD17B1 1726/4885KDM1A 1903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.